SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-30
👔
Nurix Therapeutics, Inc.
@NRIX_InsiderForm 4 Filing: van Houte Hans Sells $66,524.066 of $NRIX
INSIDER SALE
⚡ MATERIALITY: 6/10
corporate issuer
Nurix Therapeutics, Inc.
Ticker: $NRIX
Transaction Value
$66,524.066
Price/Share: $5.11
transaction date
2026-07-30
Shares: 13,025
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, van Houte Hans, holds the title of Chief Financial Officer at Nurix Therapeutics, Inc..
On 2026-07-30, the insider transacted 13,025 shares.The shares were transacted at a weighted average price of $5.11 per share, resulting in a total market-relevant value of $66,524.066.
Executive Summary Summary
van Houte Hans (Chief Financial Officer) sold $67K of $NRIX
Post-Transaction Position: 44,927 shares
SEC Accession No: 0001817217-26-000010 (CIK: 1817217)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.